EverQuote (EVER) Q4 Earnings & Revenues Surpass Estimates

EverQuote, Inc. EVER incurred a loss of 19 cents per share in fourth-quarter 2023, narrower than the Zacks Consensus Estimate of a loss of 31 cents as well as the year-ago quarter’s loss of 20 cents per share.

Total revenues of $55.7 million beat the Zacks Consensus Estimate by 11.7%. The top line declined 37% year over year, primarily attributable to weak performance in both Automotive and Other insurance verticals.

Given the prolonged auto insurance downturn, the Automotive insurance vertical’s revenues witnessed a year-over-year decline. However, a streamlined cost structure provided respite.

EverQuote, Inc. Price, Consensus and EPS Surprise EverQuote, Inc. Price, Consensus and EPS Surprise

EverQuote, Inc. price-consensus-eps-surprise-chart | EverQuote, Inc. Quote

Behind the Headlines

Revenues from the Automotive insurance vertical were $45 million, down 33% year over year. The Zacks Consensus Estimate was pegged at $38 million. Our estimate was $37.6 million.

Revenues in the Home and Renters insurance vertical totaled $9.8 million, which increased 48% year over year. The Zacks Consensus Estimate was pegged at $11.2 million. Our estimate was $10.9 million.

Revenues in the Other insurance vertical totaled $0.1 million, which plunged 93.8% year over year.

Total costs and operating expenses decreased 35.6% to $62.5 million, mainly due to lower sales and marketing, general and administrative and research and development. Our estimate was $55.8 million.

EverQuote’s variable marketing margin decreased 28.9% year over year in the quarter under review to $20.7 million. Our estimate, as well as the Zacks Consensus Estimate, was $17.3 million.

Adjusted EBITDA was negative $0.9 million versus $0.1 million earned in the year-ago quarter. Our estimate was negative $3.2 million.

Full-Year Highlights

EverQuote incurred a loss of $1.54 per share, wider than the year-ago loss of 77 cents per share.

Total revenues were $287.9 million, down 29%.

Variable marketing margin decreased 21.8% year over year to $100.3 million.

Adjusted EBITDA was $0.5 million, down 92.2% year over year.

Financial Update

EverQuote exited 2023 with cash and cash equivalents of $38 million, up 23% from 2022-end. Total assets were $111 million, down 29% from 2022-end. Total stockholders' equity decreased 24.7% to $80.9 million.

Cash used in operations was $2.8 million in 2023 versus an outflow of $15.8 million in the year-ago period.

Q1 Guidance

EverQuote estimates revenues in the range of $78-$82 million, a variable marketing margin of $26-$28 million and adjusted EBITDA in the range of $3 million-$5 million.

Zacks Rank

EverQuote currently carries a Zacks Rank #2 (Buy).  You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Performance of Other Insurers

The Travelers Companies TRV reported fourth-quarter 2023 core income of $7.01 per share, which beat the Zacks Consensus Estimate of $5.04. The bottom line more than doubled year over year, driven by higher underlying underwriting gain, lower catastrophe losses and higher net investment income. Travelers’ total revenues increased 13.5% from the year-ago quarter to $10.9 billion, primarily driven by higher premiums. The top-line figure beat the Zacks Consensus Estimate by 0.2%.

Net written premiums increased 13% year over year to about $10 billion, driven by strong growth across all three segments. The figure was higher than our estimate of $9.7 billion. TRV witnessed an underwriting gain of $1.4 billion, up more than three-fold year over year, driven by higher business volumes. The combined ratio improved 870 bps year over year to 85.8, driven by a lower underlying combined ratio and catastrophe losses.  

The Progressive Corporation’s PGR fourth-quarter 2023 earnings per share of $2.96 beat the Zacks Consensus Estimate of $2.38. The bottom line improved 97.3% year over year. Operating revenues of $16.6 billion beat the Zacks Consensus Estimate by 3% and increased 23.2% year over year.

Net premiums written were $15.1 billion in the quarter, up 21% from $12.5 billion a year ago. PGR’s premiums beat our estimate of $14 billion. Net premiums earned grew 22% to $15.8 billion and beat our estimate of $14.8 billion.

Progressive’s combined ratio improved 520 bps from the prior-year quarter’s level to 88.7.

W.R. Berkley Corporation’s WRB fourth-quarter 2023 operating income of $1.45 per share beat the Zacks Consensus Estimate of $1.35 by 7.4%. The bottom line improved 25% year over year. Operating revenues came in at $3.2 billion, up 9.3% year over year, on the back of higher net premiums earned as well as improved net investment income. The top line beat the consensus estimate by 1.3%

W.R. Berkley’s net premiums written were $2.7 billion, up 12% year over year. The figure was lower than our estimate of $2.8 billion. Pre-tax underwriting income increased 8.2% to $315.9 million. The consolidated combined ratio remained flat year over year at 88.4.

Just Released: Zacks Top 10 Stocks for 2024

Hurry – you can still get in early on our 10 top tickers for 2024. Hand-picked by Zacks Director of Research, Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2023, the Zacks Top 10 Stocks gained +974.1%, nearly TRIPLING the S&P 500’s +340.1%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2024. You can still be among the first to see these just-released stocks with enormous potential.

See New Top 10 Stocks >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

The Travelers Companies, Inc. (TRV) : Free Stock Analysis Report

W.R. Berkley Corporation (WRB) : Free Stock Analysis Report

The Progressive Corporation (PGR) : Free Stock Analysis Report

EverQuote, Inc. (EVER) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.